Evidence map›Paper›PMID 40544521›Full record

ReviewPolish journal of microbiology2025

Biomaterial-Based Scaffolds as Carriers of Topical Antimicrobials for Bone Infection Prophylaxis.

Rafał B Lewandowski

Abstract readReview
In one paragraph

Review in Polish journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rafał B LewandowskiBiomedical Engineering Centre, Institute of Optoelectronics, Military University of Technology, Warsaw, Poland.ORCID https://orcid.org/0000-0002-7134-0809

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, several modern therapies in orthopedics have been introduced, and these have been significantly influenced by the development of innovative medical devices made from various biomaterials. All orthopedic procedures involving the use of medical devices can lead to the occurrence of postoperative infectious complications, generally referred to as biomaterial-associated infections (BAIs). Currently, the classical antimicrobial treatment of BAIs consists mainly of systemic antibiotic therapy, which does not provide adequate clinical efficacy and is associated with the risk of many adverse effects. Therefore, numerous studies have been conducted to develop various methods to limit BAIs locally. Most of them involve the development of bioactive coatings or modified surfaces of biomaterials capable of releasing various antimicrobial substances. Applying such solutions in bone surgery is primarily related to the anti-infective protection of bone scaffolds, which is currently one of the most advanced and promising techniques in regenerative medicine. Using scaffolds in the damaged tissue provides an artificial structure that supports cell growth in the appropriate spatial configuration and restores the mechanical properties of the damaged bone in a short time. Therefore, the long-term protection of bone scaffolds against infection is crucial for achieving complete therapeutic success and currently represents one of the most significant challenges in bone surgery. This article presents selected strategies for modifying bone scaffolds that have been developed to reduce the risk of BAI.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsBiocompatible MaterialsBone Diseases, InfectiousProsthesis-Related InfectionsTissue ScaffoldsAnimalsBone and BonesHumansOrthopedic ProceduresAnti-Bacterial AgentsAnti-Infective AgentsBiocompatible Materialsantimicrobial scaffoldsbone infectionorthopedic device

Identifiers

PMID40544521
PMCPMC12182929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.